Timor Leste joins WHO programme as associate member Timor Leste becomes the latest associate member of WHO Programme for International Drug Monitoring.
Fifty years of putting medicines and vaccine safety at the heart of global healthcare The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.
#MedSafetyWeek encourages reporting of suspected side effects #MedSafetyWeek returns for its fifth year, spreading the word to healthcare professionals and patients alike on the importance of reporting suspected side effects of medicines.
New WHO programme members The WHO Programme for International Drug Monitoring continues to grow with three new full members and 2 new associates.
Peter Hjelmström joins UMC as new director Uppsala Monitoring Centre (UMC), the WHO Collaborating Centre for International Drug Monitoring, is pleased to announce the arrival of its new director Peter Hjelmström.
WHO pharmacovigilance manual now in 3 languages Practical WHO pharmacovigilance manual now in English, Spanish, and French.
World Patient Safety Day WHO launches new campaign, urging everyone to speak up for patient as a global health priority.
WHO programme member update – March 2021 Recent additions mean the WHO Programme for International Drug Monitoring now stands at 143 full members and 28 associate members.
Building a global network of credible vaccine safety information websites With the misinformation pandemic still rife on the internet, finding websites with scientifically accurate vaccine information is quite the task. The VSN aims to change that.
VigiFlow now free for all WHO programme members Since its introduction 20 years ago, UMC’s adverse event reporting system has become the world’s most widely used safety surveillance toolkit for medicines and vaccines.
